The home of the Audio Journal of Oncology

Tagecco

7 articles

Oncology

Oral Capecitabine: As Good As Fluorouracil Second Line for Metastatic Colorectal Cancer

February 15, 2008

AudioMedica News Oral Capecitabine: As Good As Fluorouracil Second Line for Metastatic Colorectal Cancer Play Episode Pause Episode Mute/Unmute...

$Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone$

Oncology

Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone

February 1, 2008

AudioMedica News Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone Play Episode Pause Episode...

Oncology

Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

November 16, 2007

Jean-Yves Douillard Gordon McVie REFERENCE: Abstracts: 6507 & 2LB, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007...

$Endothelin Antagonist Keeps Patients with Hormone Refractory Prostate Cancer Alive Longer$

Oncology

Endothelin Antagonist Keeps Patients with Hormone Refractory Prostate Cancer Alive Longer

November 2, 2007

Nicholas James Gordon McVie REFERENCE: Abstract: 3LB (Presidential Session), ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September...

Oncology

Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer

October 16, 2007

Jose Baselga Gordon McVie REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 JOSE BASELGA, Vall...

Oncology

Intraperitoneal Catumaxomab Prolongs Survival in Patients With Malignant Ascites from Ovarian Cancer

October 1, 2007

Markus Heiss REFERENCE: ABSTRACT 5001, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 MARKUS HEISS, Klinikum Cologne...

ECCO 2005 Oncology

Breast Cancer: Further Support for Trastuzumab from Combined Analysis

October 30, 2005

AudioMedica News Breast Cancer: Further Support for Trastuzumab from Combined Analysis Play Episode Pause Episode Mute/Unmute Episode Rewind 10...

Tagecco

Oral Capecitabine: As Good As Fluorouracil Second Line for Metastatic Colorectal Cancer

Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone

Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

Endothelin Antagonist Keeps Patients with Hormone Refractory Prostate Cancer Alive Longer

Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer

Intraperitoneal Catumaxomab Prolongs Survival in Patients With Malignant Ascites from Ovarian Cancer

Breast Cancer: Further Support for Trastuzumab from Combined Analysis

Menu

Sign up for AudioMedica.com news